BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.02B |
| 2 |
Apple
AAPL
|
+$2.03B |
| 3 |
Amazon
AMZN
|
+$1.93B |
| 4 |
Microsoft
MSFT
|
+$1.89B |
| 5 |
Uber
UBER
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$5.15B |
| 2 |
VMW
VMware, Inc
VMW
|
+$2.9B |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$2.56B |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.72B |
| 5 |
Danaher
DHR
|
+$1.02B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.07% |
| 2 | Healthcare | 12.77% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
CF Bankshares
CFBK
$229M
| $214K | ﹤0.01% |
10,985
-124
| -1% | -$2.04K |
|
4402
China Yuchai International
CYD
$1.73B
| $214K | ﹤0.01% |
25,561
-35,930
| -58% | -$320K |
|
4403
Westwater Resources
WWR
$79.1M
| $211K | ﹤0.01% |
374,307
| – | – |
|
4404
Rani Therapeutics
RANI
$87.3M
| $211K | ﹤0.01% |
63,583
| – | – |
|
4405
Electromed
ELMD
$353M
| $211K | ﹤0.01% |
19,308
-407
| -2% | -$4.25K |
|
4406
Koss Corp
KOSS
$35.7M
| $209K | ﹤0.01% |
62,532
-120
| -0.2% | -$365 |
|
4407
Lipocine
LPCN
$17.3M
| $209K | ﹤0.01% |
74,846
| – | – |
|
4408
GSI Technology
GSIT
$255M
| $206K | ﹤0.01% |
78,035
-473
| -0.6% | -$1.19K |
|
4409
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $204K | ﹤0.01% |
4,512
| – | – |
|
|
SJT
4410
San Juan Basin Royalty Trust
SJT
$121M
| $204K | ﹤0.01% |
40,064
+4,833
| +14% | +$32.3K |
|
4411
Oramed Pharmaceuticals
ORMP
$175M
| $203K | ﹤0.01% |
87,758
-1,040
| -1% | -$2.22K |
|
4412
BeyondSpring
BYSI
$32.3M
| $202K | ﹤0.01% |
224,285
-11,542
| -5% | -$10.6K |
|
4413
IGC Pharma
IGC
$27.9M
| $201K | ﹤0.01% |
717,884
| – | – |
|
4414
Mega Matrix
MPU
$14.7M
| $201K | ﹤0.01% |
142,416
-730
| -0.5% | -$785 |
|
|
DRRX
4415
DELISTED
DURECT Corp
DRRX
| $200K | ﹤0.01% |
338,855
-686
| -0.2% | -$978 |
|
4416
Euroseas
ESEA
$528M
| $199K | ﹤0.01% |
7,868
| – | – |
|
|
AXDX
4417
DELISTED
Accelerate Diagnostics
AXDX
| $199K | ﹤0.01% |
50,842
| – | – |
|
4418
Cumberland Pharmaceuticals
CPIX
$117M
| $199K | ﹤0.01% |
110,990
| – | – |
|
4419
Lightbridge
LTBR
$333M
| $198K | ﹤0.01% |
61,625
-332
| -0.5% | -$1.32K |
|
4420
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $197K | ﹤0.01% |
3,384
-204
| -6% | -$10.9K |
|
4421
Aligos Therapeutics
ALGS
$47.8M
| $197K | ﹤0.01% |
11,846
-32
| -0.3% | -$550 |
|
|
NVNO
4422
enVVeno Medical
NVNO
$6.93M
| $196K | ﹤0.01% |
1,090
+202
| +23% | +$32.2K |
|
4423
Dominari Holdings
DOMH
$63.8M
| $195K | ﹤0.01% |
75,275
| – | – |
|
4424
Vanguard Communication Services ETF
VOX
$5.88B
| $195K | ﹤0.01% |
1,656
+1,392
| +527% | +$154K |
|
4425
DarioHealth
DRIO
$74.7M
| $194K | ﹤0.01% |
5,631
+236
| +4% | +$8.4K |
|
Similar funds
BlackRock's Q4 2023 Portfolio in Review
As of Q4 2023, BlackRock held 5,578 positions worth $3.92T, up 13% from $3.48T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BlackRock's Q4 2023 filing shows 129 new, 3,072 increased, 1,515 reduced and 203 closed positions. Its largest new stake was NCR Atleos: 8,735,537 shares worth $212M. The largest sale was Activision Blizzard, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2023 buy was NCR Atleos: 8,735,537 shares worth $212M.
- BlackRock added most to Broadcom in Q4 2023, an estimated $3.02B increase.
- BlackRock's biggest Q4 2023 reduction was Danaher, cutting an estimated $1.02B.
- BlackRock fully exited Activision Blizzard in Q4 2023, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 22% of its $3.92T portfolio in Q4 2023.
- BlackRock opened 129 new positions and closed 203 in Q4 2023.
- BlackRock's portfolio value rose 13% quarter-over-quarter to $3.92T.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.